Stocks News

LAST PRICE
30.6000
TODAY'S CHANGE (%)
Trending Up0.5300 (1.7626%)

Bid / Lots
29.0000/ 10
Ask / Lots
40.0000/ 4
Open / Previous Close
30.3500 / 30.0700
Day Range
Low 30.3500
High 31.2700
52 Week Range
Low 21.9900
High 38.0900
Volume
365,488
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Yesterday
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN, from 10:15AM ET on Sunday Apr 28, 2024 by PR Newswire
  10:15AM ET on Sunday Apr 28, 2024 by PR Newswire
  Companies Mentioned: SUPN
  Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. ("Supernus"or the "Company")(NASDAQ: SUPN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext. 7980.
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN, from 10:15AM ET on Sunday Apr 28, 2024 by Dow Jones
  10:15AM ET on Sunday Apr 28, 2024 by Dow Jones
  Companies Mentioned: SUPN
  
  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
  
  PR Newswire
  
  NEW YORK, April 28, 2024
Apr 26, 2024
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN, from 12:03PM ET on Friday Apr 26, 2024 by Accesswire
  12:03PM ET on Friday Apr 26, 2024 by Accesswire
  Companies Mentioned: SUPN
  NEW YORK, NY / ACCESSWIRE / April 26, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. ("Supernus" or the "Company") (NASDAQ:SUPN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN, from 12:03PM ET on Friday Apr 26, 2024 by Dow Jones
  12:03PM ET on Friday Apr 26, 2024 by Dow Jones
  Companies Mentioned: SUPN
  
  NEW YORK, NY / ACCESSWIRE / April 26, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. ("Supernus" or the "Company") (NASDAQ:SUPN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Apr 24, 2024
- Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024, from 4:06PM ET on Wednesday Apr 24, 2024 by GlobeNewswire
  4:06PM ET on Wednesday Apr 24, 2024 by GlobeNewswire
  Companies Mentioned: SUPN

Today
- Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET, from 1 hour ago by PR Newswire
  1 hour ago by PR Newswire
  Companies Mentioned: SHWZ
- Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET, from 1 hour ago by CNW Group
  1 hour ago by CNW Group
  Companies Mentioned: SHWZ
- Zoetis to Sell Medicated Feed Additives Business to Phibro Animal Health for $350 Million, from 13 hours ago by MT Newswires
  13 hours ago by MT Newswires
  Companies Mentioned: ZTS, PAHC
Apr 22, 2024
- PetIQ, Inc. to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024, from 4:15PM ET on Monday Apr 22, 2024 by GlobeNewswire
  4:15PM ET on Monday Apr 22, 2024 by GlobeNewswire
  Companies Mentioned: PETQ
Apr 17, 2024
- Lifshitz Law PLLC Announces Investigations of InMode Ltd. (NASDAQ: INMD), General Motors Company (NYSE: GM), Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX), and Driven Brands Holdings Inc. (NASDAQ: DRVN), from 6:02AM ET on Wednesday Apr 17, 2024 by Accesswire
  6:02AM ET on Wednesday Apr 17, 2024 by Accesswire
  Companies Mentioned: INMD, DRVN, EGRX
Apr 15, 2024
- Sector Update: Health Care Stocks Softer Late Afternoon, from 3:59PM ET on Monday Apr 15, 2024 by MT Newswires
  3:59PM ET on Monday Apr 15, 2024 by MT Newswires
  Companies Mentioned: HUM, ELV, SNGX, EGRX, MRNS, CNC
- Sector Update: Health Care, from 3:31PM ET on Monday Apr 15, 2024 by MT Newswires
  3:31PM ET on Monday Apr 15, 2024 by MT Newswires
  Companies Mentioned: EGRX
- Eagle Pharmaceuticals Says Phase 3 Data Show Amisulpride's Sustained Antiemetic Effect; Shares Rise, from 1:49PM ET on Monday Apr 15, 2024 by MT Newswires
  1:49PM ET on Monday Apr 15, 2024 by MT Newswires
  Companies Mentioned: EGRX
- Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea and Vomiting (PONV) at the Upcoming ASPAN 2024 National Conference in Orlando, Florida, from 7:00AM ET on Monday Apr 15, 2024 by GlobeNewswire
  7:00AM ET on Monday Apr 15, 2024 by GlobeNewswire
  Companies Mentioned: EGRX
Apr 12, 2024
- Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K, from 4:06PM ET on Friday Apr 12, 2024 by GlobeNewswire
  4:06PM ET on Friday Apr 12, 2024 by GlobeNewswire
  Companies Mentioned: EGRX

Supernus Pharmaceuticals Inc
NASDAQ:SUPNUnited States

Search Criteria

Yesterday

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN, from 10:15AM ET on Sunday Apr 28, 2024 by PR Newswire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN, from 10:15AM ET on Sunday Apr 28, 2024 by Dow Jones

Apr 26, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN, from 12:03PM ET on Friday Apr 26, 2024 by Accesswire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN, from 12:03PM ET on Friday Apr 26, 2024 by Dow Jones

Apr 24, 2024

Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024, from 4:06PM ET on Wednesday Apr 24, 2024 by GlobeNewswire

Peers Headlines

Today

Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET, from 1 hour ago by PR Newswire

Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET, from 1 hour ago by CNW Group

Zoetis to Sell Medicated Feed Additives Business to Phibro Animal Health for $350 Million, from 13 hours ago by MT Newswires

Apr 22, 2024

PetIQ, Inc. to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024, from 4:15PM ET on Monday Apr 22, 2024 by GlobeNewswire

Apr 17, 2024

Lifshitz Law PLLC Announces Investigations of InMode Ltd. (NASDAQ: INMD), General Motors Company (NYSE: GM), Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX), and Driven Brands Holdings Inc. (NASDAQ: DRVN), from 6:02AM ET on Wednesday Apr 17, 2024 by Accesswire

Apr 15, 2024

Sector Update: Health Care Stocks Softer Late Afternoon, from 3:59PM ET on Monday Apr 15, 2024 by MT Newswires

Sector Update: Health Care, from 3:31PM ET on Monday Apr 15, 2024 by MT Newswires

Eagle Pharmaceuticals Says Phase 3 Data Show Amisulpride's Sustained Antiemetic Effect; Shares Rise, from 1:49PM ET on Monday Apr 15, 2024 by MT Newswires

Apr 12, 2024

Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K, from 4:06PM ET on Friday Apr 12, 2024 by GlobeNewswire